Myriad Genetics to Release Fourth-Quarter Financial Results
SALT LAKE CITY, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing
Globe Newswire22-02-2023, 19:06
Schneider’s sustainability program heads full speed toward its end-year targets with strong local impact 30-10-2024, 14:38